• EMS-Chemie reported H1 2026 EBIT up 4.7% to CHF 310 million; EBIT margin widened 1.5 percentage points to 30.6%.
• Net sales slipped to CHF 1.01 billion, despite 4.5% growth in local currencies, as the Swiss franc strengthened sharply.
• EBITDA rose 3.9% to CHF 336 million; EBITDA margin increased 1.5 percentage points to 33.2%.
• Management flagged a volatile trade-policy backdrop, a stronger Swiss franc and higher energy prices, while citing rising volumes and growth in high-margin new business.
• For 2026, EMS nudged its net sales view slightly higher but still sees net sales slightly below last year, while keeping its EBIT outlook slightly above.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EMS-Chemie Holding AG published the original content used to generate this news brief on July 10, 2026, and is solely responsible for the information contained therein.